U.S. Markets closed

Alligator Bioscience AB (publ) (ATORX.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
6.11-0.09 (-1.45%)
At close: 5:29PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.12
Open6.25
Bid6.20 x 0
Ask6.24 x 0
Day's Range6.15 - 6.35
52 Week Range5.88 - 11.03
Volume157,548
Avg. Volume121,679
Market Cap523.421M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-2.01
Earnings DateApr 27, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est44.00
  • PR Newswire

    Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy

    Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the expansion of Alligator's proprietary patient specific immunotherapy Neo-X-Prime™ by incorporating MacroGenics' proprietary DART® and TRIDENT® multi-specific platforms against two undisclosed targets.

  • PR Newswire

    Alligator Bioscience postpones the Annual General Meeting to June 1, 2021

    Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the board of directors has decided to postpone the Annual General Meeting to June 1, 2021, in connection with that Søren Bregenholt takes office as new CEO of Alligator.

  • PR Newswire

    Alligator Bioscience appoints Søren Bregenholt as new CEO

    Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søren Bregenholt, Ph.D. as the company's new Chief Executive Officer (CEO), to strengthen Alligator's business development activities and clinical progress on an international level. Dr. Søren Bregenholt will take up the position on 1 June 2021, succeeding Per Norlén, who will remain in the company. In order to facilitate the transition, Malin Carlsson, Alligator's COO, is appointed as interim CEO.